SANOFI AVENTIS vs INTAS PHARMACEUTICALS LTD. & ANR

Judgment text excerpt

* IN THE HIGH COURT OF DELHI AT NEW DELHI % Judgment Reserved on: 19th March, 2026 Judgment pronounced on: 28th April, 2026 + CS(COMM) 120/2016 SANOFI .....Plaintiff Through: Mr. Pravin Anand, Ms. Vaishali Mittal and Mr. Siddhant Chamola, Advocates versus INTAS PHARMACEUTICALS LTD. & ANR. .....Defendants Through: Mr. Rajiv Nayar and Mr. C.M. Lall, Senior Advocates with Ms. Vrinda Pathak, Mr. P.S. Manjunathan, Ms. Rinkoo Kakkar, Ms. Annanya, Mr. Rajnish Kumar and Ms. Sandhya Kukreti, Advocates CORAM: HON'BLE MR. JUSTICE AMIT BANSAL JUDGMENT AMIT BANSAL, J. 1. The present suit has been filed seeking relief of permanent injunction restraining the defendants from infringing the trade marks of the plaintiff and from passing off of their goods as those of the plaintiff along with other ancillary reliefs. CASE SETUP BY THE PLAINTIFF 2. Brief facts relevant for adjudicating the present suit are as follows: 2.1. The plaintiff, a company registered under the laws of France, is engaged in research, development, manufacturing and marketing of inter alia medicinal and pharmaceutical preparations. Signature Not Verified Signed By:VIVEK MISHRA CS(COMM) 120/2016 Page 1 of 64 Signing Date:28.04.2026 15:48:26 2.2. The plaintiff is one of the world’s leading pharmaceutical companies and has over the years manufactured and sold a number of pharmaceutical products under several trade marks across the world including India. 2.3. One of the most renowned drugs of the plaintiff is its anti-thrombosis drug, namely PLAVIX which helps prevent heart attacks and strokes. 2.4. The trade mark PLAVIX was coined in the year 1995. 2.5. The plaintiff filed an application bearing no.806651 for registration of the device mark in class 5 on 17th June 1998, which was granted on 25th August 2005. The plaintif